GCAM, GC’s sister company, said Friday that it has added two additional plasma collection centers in the U.S. -- one located in Indianapolis, Ind., and the other in Pasco, Wash.
The two new centers can each produce up to 50,000 liters of raw plasma per year.
Human plasma is the essential source for products for treating patients suffering from many different life-threatening disease and conditions, including immune deficiencies, hemophilia, and other blood disorders.
With the latest additions, GCAM now runs 10 plasma collection centers in the U.S.
GC plans to increase further the number of plasma centers in line with the operation of its Canadian factory, which the company intends to use as a production base for North American blood products.
“We are increasing the number of plasma center at the right time for our successful advance into the U.S.,” GCAM President Jay Bae said. “The company plans to increase the number of plasma centers to more than 20 places and secure more than 1 million liters of raw plasma per year.”
<© Korea Biomedical Review, All rights reserved.>